Abstract | BACKGROUND: MATERIALS AND METHODS: Specimens from 85 patients with CRC were immunostained with a monoclonal antibody against PS-PLA1. The correlation between PS-PLA1 expression and the clinicopathological variables was analyzed. RESULTS:
Tumor depth and hematogenous metastasis independently positively correlated with PS-PLA1 expression. High PS-PLA1 expression was associated with shorter disease-free survival, although it was not an independent predictive factor. CONCLUSION: PS-PLA1 expression in CRC is associated with tumor invasion and metastasis.
|
Authors | Yuuki Iida, Eiji Sunami, Hiroharu Yamashita, Masaya Hiyoshi, Soichiro Ishihara, Hironori Yamaguchi, Asuka Inoue, Kumiko Makide, Nelson H Tsuno, Junken Aoki, Joji Kitayama, Toshiaki Watanabe |
Journal | Anticancer research
(Anticancer Res)
Vol. 35
Issue 3
Pg. 1459-64
(Mar 2015)
ISSN: 1791-7530 [Electronic] Greece |
PMID | 25750298
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright© 2015 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved. |
Chemical References |
- Phosphatidylserines
- Phospholipases A1
|
Topics |
- Aged
- Colorectal Neoplasms
(enzymology, pathology)
- Disease-Free Survival
- Female
- Humans
- Male
- Middle Aged
- Neoplasm Invasiveness
- Neoplasm Metastasis
- Neoplastic Cells, Circulating
- Phosphatidylserines
(metabolism)
- Phospholipases A1
(analysis, physiology)
|